Xenetic Biosciences Inc.

NASDAQ: XBIO · Real-Time Price · USD
2.92
-0.07 (-2.34%)
At close: Aug 14, 2025, 3:55 PM
2.81
-3.93%
Pre-market: Aug 15, 2025, 07:58 AM EDT

Xenetic Biosciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.55 -1.28 -0.63 -2.39
PEG Ratio
0.30 0.03 0.04 0.03
PS Ratio
2.46 2.08 2.38 11.42
PB Ratio
1.02 0.54 0.30 0.72
P/FCF Ratio
-2.18 -1.28 -0.79 -2.8
P/OCF Ratio
-2.18 -1.28 -0.87 -2.8
OCF/S Ratio
-1.13 -1.62 -2.72 -4.08
Debt / Equity Ratio
n/a n/a n/a 0.00
Quick Ratio
7.37 11.84 12.72 13.18
Current Ratio
7.37 11.84 12.72 13.18
Asset Turnover
0.36 0.24 0.12 0.06
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.66 -0.42 -0.47 -0.3
Return on Assets
-0.57 -0.39 -0.43 -0.28
Return on Invested Capital
-0.7 -0.46 -0.48 -0.31
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.98 0.97
Net Profit Margin
-1.58 -1.63 -3.74 -4.78
Pretax Profit Margin
-1.58 -1.63 -3.84 -4.86
Operating Profit Margin
-1.68 -1.78 -3.94 -4.95
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.68 -1.78 -3.94 -4.92